Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1993 Sep;68(3):475–483. doi: 10.1038/bjc.1993.373

Growth of cultured human glioma tumour cells can be regulated with histamine and histamine antagonists.

L T Van der Ven 1, I M Prinsen 1, G H Jansen 1, P J Roholl 1, R Defferrari 1, R Slater 1, W Den Otter 1
PMCID: PMC1968386  PMID: 8353038

Abstract

The 50% survival time for low grade astrocytomas is 50 months and for high grade astrocytomas it is 13 months, underlining the need for new therapies. Several reports show that in vivo histamine antagonists cause retardation of tumour growth in some animal models and prolonged survival in cancer patients. Therefore we have tested the growth modulating effects of histamine and histamine antagonists on human glioma cultures. Twelve freshly excised human gliomas were cultured and tested for their in vitro sensitivity to histamine and histamine antagonists. Four continuous glioma cell lines were used to confirm the glioma-specificity of the effects observed in the primary cell lines. In low serum concentration (0 or 1%) the growth of 5/9 primary glioma-derived cultures could be stimulated with 0.2 mM histamine, and in 4/5 cases with 0.2 microM histamine. One mM of the histamine H2-receptor antagonist cimetidine could inhibit the growth of 4/5 primary glioma cultures when tested in 1% human AB serum, and of 6/13 cases when tested in 1% FCS. Lower concentrations (down to 1 microM) were less effective. The histamine H1-receptor antagonist pyrilamine gave variable results. The specificity of the effects is indicated by the absence of a generalised toxic effect, by the observation that the antagonist-induced inhibition could be reversed with histamine, and by the correlation of the obtained cimetidine-induced growth inhibition with the maximal growth rate of the primary cell lines in 10% FCS. The observed cimetidine-induced inhibition of the in vitro proliferation of gliomas suggests that cimetidine is a relevant candidate for the in vivo growth inhibition of these tumours.

Full text

PDF
475

Images in this article

478Figure 1
on p.478
479Figure 2
on p.479

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahlstrom C. G., Johnston M., Kahlson G. Histamine formation in tumor-bearing rats. Life Sci. 1966 Sep;5(18):1633–1640. doi: 10.1016/0024-3205(66)90100-7. [DOI] [PubMed] [Google Scholar]
  2. Armitage J. O., Sidner R. D. Antitumour effect of cimetidine. Lancet. 1979 Apr 21;1(8121):882–883. doi: 10.1016/s0140-6736(79)91306-0. [DOI] [PubMed] [Google Scholar]
  3. Arnoldus E. P., Noordermeer I. A., Peters A. C., Voormolen J. H., Bots G. T., Raap A. K., van der Ploeg M. Interphase cytogenetics of brain tumors. Genes Chromosomes Cancer. 1991 Mar;3(2):101–107. doi: 10.1002/gcc.2870030204. [DOI] [PubMed] [Google Scholar]
  4. Bigner S. H., Mark J., Burger P. C., Mahaley M. S., Jr, Bullard D. E., Muhlbaier L. H., Bigner D. D. Specific chromosomal abnormalities in malignant human gliomas. Cancer Res. 1988 Jan 15;48(2):405–411. [PubMed] [Google Scholar]
  5. Bigner S. H., Mark J. Chromosome and chromosomal progression of human gliomas in vivo, in vitro and in athymic nude mice. Prog Exp Tumor Res. 1984;27:67–82. doi: 10.1159/000408223. [DOI] [PubMed] [Google Scholar]
  6. Bijman J. T., Wagener D. J., Graafsma S. J., Wessels J. M., Van den Broek P. Modulation of proliferation of a human head and neck squamous carcinoma cell line (HN-1) by catecholamines and histamine. Anticancer Res. 1987 Mar-Apr;7(2):147–150. [PubMed] [Google Scholar]
  7. Burtin C., Noirot C., Scheinmann P., Galoppin L., Sabolovic D., Bernard P. Clinical improvement in advanced cancer disease after treatment combining histamine and H2-antihistaminics (ranitidine or cimetidine). Eur J Cancer Clin Oncol. 1988 Feb;24(2):161–167. doi: 10.1016/0277-5379(88)90247-7. [DOI] [PubMed] [Google Scholar]
  8. Burtin C., Scheinmann P., Salomon J. C., Lespinats G., Canu P. Decrease in tumour growth by injections of histamine or serotonin in fibrosarcoma-bearing mice: influence of H1 and H2 histamine receptors. Br J Cancer. 1982 Jan;45(1):54–60. doi: 10.1038/bjc.1982.7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Daumas-Duport C., Scheithauer B., O'Fallon J., Kelly P. Grading of astrocytomas. A simple and reproducible method. Cancer. 1988 Nov 15;62(10):2152–2165. doi: 10.1002/1097-0142(19881115)62:10<2152::aid-cncr2820621015>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  10. Den Otter W., Koten J. W., Van der Vegt B. J., Beemer F. A., Boxma O. J., Derkinderen D. J., De Graaf P. W., Huber J., Lips C. J., Roholl P. J. Oncogenesis by mutations in anti-oncogenes: a view. Anticancer Res. 1990 Mar-Apr;10(2B):475–487. [PubMed] [Google Scholar]
  11. Forsby N., Collins V. P., Brunk U. T., Fredrikson B. A., Westermark B. Translocation of human glial and glioma cells in culture. Virchows Arch B Cell Pathol Incl Mol Pathol. 1986;51(1):3–15. doi: 10.1007/BF02899011. [DOI] [PubMed] [Google Scholar]
  12. Heim S., Mandahl N., Jin Y., Strömblad S., Lindström E., Salford L. G., Mitelman F. Trisomy 7 and sex chromosome loss in human brain tissue. Cytogenet Cell Genet. 1989;52(3-4):136–138. doi: 10.1159/000132863. [DOI] [PubMed] [Google Scholar]
  13. Ito M., Nagashima T., Hoshino T. Quantitation and distribution analysis of glial fibrillary acidic protein in human glioma cells in culture. J Neuropathol Exp Neurol. 1989 Sep;48(5):560–567. doi: 10.1097/00005072-198909000-00006. [DOI] [PubMed] [Google Scholar]
  14. Johnson C. L., Johnson C. G. Inhibition of human skin fibroblast proliferation by histamine and phorbol esters is mediated by protein kinase C. Cell Signal. 1990;2(2):105–113. doi: 10.1016/0898-6568(90)90014-2. [DOI] [PubMed] [Google Scholar]
  15. Johnston M. Histamine formation in rats bearing the Walker mammary carcinosarcoma. Experientia. 1967 Feb 15;23(2):152–154. doi: 10.1007/BF02135977. [DOI] [PubMed] [Google Scholar]
  16. Jordana M., Befus A. D., Newhouse M. T., Bienenstock J., Gauldie J. Effect of histamine on proliferation of normal human adult lung fibroblasts. Thorax. 1988 Jul;43(7):552–558. doi: 10.1136/thx.43.7.552. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. KAHLSON G., ROSENGREN E., STEINHARDT C. HISTAMINE-FORMING CAPACITY OF MULTIPLYING CELLS. J Physiol. 1963 Dec;169:487–498. doi: 10.1113/jphysiol.1963.sp007274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kahlson G., Rosengren E. New approaches to the physiology of histamine. Physiol Rev. 1968 Jan;48(1):155–196. doi: 10.1152/physrev.1968.48.1.155. [DOI] [PubMed] [Google Scholar]
  19. Kimmel D. W., O'Fallon J. R., Scheithauer B. W., Kelly P. J., Dewald G. W., Jenkins R. B. Prognostic value of cytogenetic analysis in human cerebral astrocytomas. Ann Neurol. 1992 May;31(5):534–542. doi: 10.1002/ana.410310512. [DOI] [PubMed] [Google Scholar]
  20. Kornblith P. L., Walker M. Chemotherapy for malignant gliomas. J Neurosurg. 1988 Jan;68(1):1–17. doi: 10.3171/jns.1988.68.1.0001. [DOI] [PubMed] [Google Scholar]
  21. Leibel S. A., Sheline G. E. Radiation therapy for neoplasms of the brain. J Neurosurg. 1987 Jan;66(1):1–22. doi: 10.3171/jns.1987.66.1.0001. [DOI] [PubMed] [Google Scholar]
  22. Nazzaro J. M., Neuwelt E. A. The role of surgery in the management of supratentorial intermediate and high-grade astrocytomas in adults. J Neurosurg. 1990 Sep;73(3):331–344. doi: 10.3171/jns.1990.73.3.0331. [DOI] [PubMed] [Google Scholar]
  23. Nistér M., Heldin C. H., Westermark B. Clonal variation in the production of a platelet-derived growth factor-like protein and expression of corresponding receptors in a human malignant glioma. Cancer Res. 1986 Jan;46(1):332–340. [PubMed] [Google Scholar]
  24. Olopade O. I., Jenkins R. B., Ransom D. T., Malik K., Pomykala H., Nobori T., Cowan J. M., Rowley J. D., Diaz M. O. Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas. Cancer Res. 1992 May 1;52(9):2523–2529. [PubMed] [Google Scholar]
  25. Onda K., Tanaka R., Washiyama K., Takeda N., Kumanishi T. Correlation of DNA ploidy and morphological features of human glioma cell cultures with the establishment of cell lines. Acta Neuropathol. 1988;76(5):433–440. doi: 10.1007/BF00686381. [DOI] [PubMed] [Google Scholar]
  26. Panettieri R. A., Yadvish P. A., Kelly A. M., Rubinstein N. A., Kotlikoff M. I. Histamine stimulates proliferation of airway smooth muscle and induces c-fos expression. Am J Physiol. 1990 Dec;259(6 Pt 1):L365–L371. doi: 10.1152/ajplung.1990.259.6.L365. [DOI] [PubMed] [Google Scholar]
  27. Pelletier B., Dhainaut F., Pauly A., Zahnd J. P. Evaluation of growth rate in adhering cell cultures using a simple colorimetric method. J Biochem Biophys Methods. 1988 May;16(1):63–73. doi: 10.1016/0165-022x(88)90104-2. [DOI] [PubMed] [Google Scholar]
  28. Pleasure D., Kreider B., Sobue G., Ross A. H., Koprowski H., Sonnenfeld K. H., Rubenstein A. E. Schwann-like cells cultured from human dermal neurofibromas. Immunohistological identification and response to Schwann cell mitogens. Ann N Y Acad Sci. 1986;486:227–240. doi: 10.1111/j.1749-6632.1986.tb48076.x. [DOI] [PubMed] [Google Scholar]
  29. Pontén J., Macintyre E. H. Long term culture of normal and neoplastic human glia. Acta Pathol Microbiol Scand. 1968;74(4):465–486. doi: 10.1111/j.1699-0463.1968.tb03502.x. [DOI] [PubMed] [Google Scholar]
  30. Ransom D. T., Ritland S. R., Moertel C. A., Dahl R. J., O'Fallon J. R., Scheithauer B. W., Kimmel D. W., Kelly P. J., Olopade O. I., Diaz M. O. Correlation of cytogenetic analysis and loss of heterozygosity studies in human diffuse astrocytomas and mixed oligo-astrocytomas. Genes Chromosomes Cancer. 1992 Nov;5(4):357–374. doi: 10.1002/gcc.2870050412. [DOI] [PubMed] [Google Scholar]
  31. Rodriguez J., Moran J., Blanco I., Patel A. J. Effect of histamine on the development of astroglial cells in culture. Neurochem Res. 1989 Jul;14(7):693–700. doi: 10.1007/BF00964881. [DOI] [PubMed] [Google Scholar]
  32. Schneider E., Piquet-Pellorce C., Dy M. New role for histamine in interleukin-3-induced proliferation of hematopoietic stem cells. J Cell Physiol. 1990 May;143(2):337–343. doi: 10.1002/jcp.1041430218. [DOI] [PubMed] [Google Scholar]
  33. Scotcher S., Sikora K., Freedman L. Gastric cancer and cimetidine: does delay in diagnosis matter? Lancet. 1981 Sep 19;2(8247):630–631. doi: 10.1016/s0140-6736(81)92759-8. [DOI] [PubMed] [Google Scholar]
  34. Shapiro W. R., Shapiro J. R. Principles of brain tumor chemotherapy. Semin Oncol. 1986 Mar;13(1):56–69. [PubMed] [Google Scholar]
  35. Smith M. T., Ludwig C. L., Godfrey A. D., Armbrustmacher V. W. Grading of oligodendrogliomas. Cancer. 1983 Dec 1;52(11):2107–2114. doi: 10.1002/1097-0142(19831201)52:11<2107::aid-cncr2820521123>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  36. Spaar F. W., Spaar U. DNA in human glioblastomas. A flow-fluorescence cytometrical examination of 96 tumors. Neurosurg Rev. 1990;13(2):123–139. doi: 10.1007/BF00383653. [DOI] [PubMed] [Google Scholar]
  37. Sporn M. B., Roberts A. B. Autocrine growth factors and cancer. 1985 Feb 28-Mar 6Nature. 313(6005):745–747. doi: 10.1038/313745a0. [DOI] [PubMed] [Google Scholar]
  38. Sporn M. B., Roberts A. B. Peptide growth factors are multifunctional. Nature. 1988 Mar 17;332(6161):217–219. doi: 10.1038/332217a0. [DOI] [PubMed] [Google Scholar]
  39. Stewart P. A., Hayakawa K., Hayakawa E., Farrell C. L., Del Maestro R. F. A quantitative study of blood-brain barrier permeability ultrastructure in a new rat glioma model. Acta Neuropathol. 1985;67(1-2):96–102. doi: 10.1007/BF00688129. [DOI] [PubMed] [Google Scholar]
  40. Tilly B. C., Tertoolen L. G., Remorie R., Ladoux A., Verlaan I., de Laat S. W., Moolenaar W. H. Histamine as a growth factor and chemoattractant for human carcinoma and melanoma cells: action through Ca2(+)-mobilizing H1 receptors. J Cell Biol. 1990 Apr;110(4):1211–1215. doi: 10.1083/jcb.110.4.1211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Tutton P. J., Barkla D. H. Biogenic amines as regulators of the proliferative activity of normal and neoplastic intestinal epithelial cells (review). Anticancer Res. 1987 Jan-Feb;7(1):1–12. [PubMed] [Google Scholar]
  42. Tutton P. J., Barkla D. H. Stimulation of cell proliferation by histamine H2 receptors in dimethylhdrazine-induced adenocarcinomata. Cell Biol Int Rep. 1978 Mar;2(2):199–202. doi: 10.1016/0309-1651(78)90043-7. [DOI] [PubMed] [Google Scholar]
  43. Tutton P. J., Steel G. G. Influence of biogenic amines on the growth of xenografted human colorectal carcinomas. Br J Cancer. 1979 Nov;40(5):743–749. doi: 10.1038/bjc.1979.255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Tønnesen H., Knigge U., Bülow S., Damm P., Fischerman K., Hesselfeldt P., Hjortrup A., Pedersen I. K., Pedersen V. M., Siemssen O. J. Effect of cimetidine on survival after gastric cancer. Lancet. 1988 Oct 29;2(8618):990–992. doi: 10.1016/s0140-6736(88)90743-x. [DOI] [PubMed] [Google Scholar]
  45. Westermark B., Nister M., Heldin C. H. Growth factors and oncogenes in human malignant glioma. Neurol Clin. 1985 Nov;3(4):785–799. [PubMed] [Google Scholar]
  46. Wolff M., Böker D. K. Immunohistochemical demonstration of immunoglobulins and albumin in human brain tumors. Clin Neuropathol. 1989 Mar-Apr;8(2):72–78. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES